Fennel

Metadata

• Common Names: Fennel, Sweet Fennel, Bitter Fennel (English); Fenchel (German)
• Botanical Name: Foeniculum vulgare Mill.
• Plant Family: Apiaceae (Umbelliferae)
• Part Used: Fruit/seed (Foeniculi fructus); Essential oil (Foeniculi aetheroleum)
• Evidence Quality Rating: Moderate (good pharmacological data; moderate clinical evidence, especially for infantile colic)

Approved Indications

Commission E

• Dyspeptic complaints
• Mild spasmodic gastrointestinal ailments
• Bloating and flatulence
• Catarrh of the upper respiratory tract (expectorant)

ESCOP

• Dyspeptic complaints such as mild, spasmodic gastrointestinal ailments
• Bloating and flatulence
• Catarrhs of the upper respiratory tract
• Pediatric use: Dyspeptic complaints in children (including infantile colic in combination products)

EMA/HMPC

• Well-established use (bitter fennel fruit): Spasmodic gastrointestinal complaints; catarrhs of the upper respiratory tract
• Traditional use (sweet fennel fruit): Symptomatic treatment of mild, spasmodic gastrointestinal complaints including bloating and flatulence
• Traditional use: Symptomatic treatment of mild spasmodic gastrointestinal complaints in children and adolescents
• Note: The EMA withdrew its monograph on bitter fennel essential oil due to new findings on genotoxicity/carcinogenicity of estragole
• Sweet fennel (var. dulce) and bitter fennel (var. vulgare) have separate regulatory assessments

Agreement/Disagreement Between Bodies

• All three bodies agree on dyspepsia, GI spasms, flatulence, and respiratory catarrh
• All recognize pediatric applicability (unusual for herbal medicines)
• The EMA notably distinguishes between sweet and bitter fennel varieties
• The estragole safety concern led EMA to withdraw the bitter fennel oil monograph — this is a significant regulatory action
• ESCOP explicitly includes pediatric use for dyspeptic complaints
• Bitter fennel fruit (not oil) retains well-established use status for spasmodic GI complaints

Conditions Treated

• Functional dyspepsia
• Bloating / Flatulence
• Mild gastrointestinal spasms
• Infantile colic
• Upper respiratory catarrh / Productive cough
• Feelings of fullness

Mechanism of Action

• trans-Anethole (60-80% of essential oil in sweet fennel): Primary active compound; smooth muscle relaxant; structurally similar to dopamine and adrenaline, may compete at receptor sites; mild estrogenic activity
• Fenchone (12-25% in bitter fennel, 1-10% in sweet fennel): Expectorant; increases bronchial secretions; antimicrobial
• Estragole (methyl chavicol) (1-10%): Contributing antispasmodic; genotoxic carcinogen at high doses in animal models (see Safety section)
• Carminative mechanism: Relaxation of GI smooth muscle; reduction of intestinal gas formation; promotion of peristalsis at low doses
• Antispasmodic activity: Direct smooth muscle relaxation via calcium channel modulation and acetylcholine antagonism
• Secretolytic effect: In respiratory tract, increases mucociliary clearance
• Anti-inflammatory: Anethole inhibits TNF-alpha-mediated NF-kB activation
• Gastric motility: Recent research (2025) demonstrates fennel tea has region-specific effects on stomach motility, with relaxation of the gastric fundus and stimulation of the antrum

Clinical Evidence Summary

Infantile Colic

• Alexandrovich et al. (2003): RCT (n=125); fennel seed oil emulsion (0.1% Foeniculum vulgare, 5-20 mL, up to 4 times daily) vs placebo; colic-free in 65% of fennel group vs 23.7% of placebo (p<0.01); significant reduction in crying time [J Alt Complement Med]
• Savino et al. (2005): RCT of herbal tea containing fennel, chamomile, vervain, licorice, and lemon balm; significant improvement in colic symptoms vs placebo
• The infantile colic evidence is among the strongest clinical data for fennel

Dysmenorrhea

• Multiple RCTs demonstrate fennel extract reduces menstrual pain intensity (relevant to the antispasmodic mechanism but not GI-specific)

Dyspepsia

• Clinical evidence for dyspepsia specifically is primarily from traditional use documentation and combination studies (including fennel as component of STW 5/Iberogast)
• Direct RCT evidence for fennel monotherapy in adult dyspepsia is limited [NEEDS-RESEARCH]

Pharmacological Data

• In vivo experiments confirmed secretolytic, expectorant, estrogenic, anti-genotoxic, analgesic, anti-thrombotic, and anti-hepatotoxic properties
• Strong preclinical evidence for GI smooth muscle relaxation

European vs US/Anglophone Consensus

• Fennel tea is a traditional first-line remedy for infant colic in Germany, Italy, and across continental Europe; pediatricians commonly recommend it
• In the US, fennel is primarily a culinary ingredient; therapeutic use for colic or dyspepsia is niche
• European pharmacies stock fennel-based infant preparations (Fencheltee fur Babys); US pediatricians rarely recommend fennel
• The estragole safety debate is more prominent in European regulatory discussions; US/FDA has not issued specific guidance
• European tradition of combining fennel with anise and caraway for GI complaints has no parallel in US practice

Safety Profile

Contraindications

• Known allergy to Apiaceae family (celery, caraway, dill, anise, coriander)
• Estrogen-sensitive conditions (fennel has mild estrogenic activity due to anethole)
• Not for use in children under 4 years as tea (EMA guidance) without medical supervision

Drug Interactions

• Potential interaction with estrogen-containing medications (additive estrogenic effect)
• May interact with ciprofloxacin (reduced absorption reported in one study)
• Theoretical interaction with anticoagulants (limited data)
• No known severe drug interactions

Side Effects

• Generally well tolerated at recommended doses
• Rare allergic reactions (including photodermatitis)
• Contact sensitization (occupational exposure)
• Nausea at high doses

Estragole Safety Concern

• Critical regulatory issue: Estragole is classified as a genotoxic carcinogen (EMA/HMPC assessment)
• In isolated form, estragole causes hepatocellular carcinoma in rodents at high doses
• Metabolism and carcinogenic activation are dose-dependent; relative importance diminishes markedly at low exposure levels
• At normal human dietary exposure (0.5-5 mg/day from food), carcinogenic risk is considered minimal
• The complex matrix of fennel preparations may provide protective effects that inactivate estragole’s genotoxic activity
• EMA restriction: Adults/adolescents max 2 weeks use; children 4-12 years max 1 week; daily estragole intake should not exceed 1.0 microg/kg body weight
• EMA withdrew the bitter fennel oil monograph but retained fruit monographs (lower estragole concentration)

Pregnancy/Lactation

• Traditionally used as a galactagogue (to promote milk production)
• Estrogenic activity raises theoretical concerns in pregnancy; daily estragole intake should not exceed 1.0 mg during pregnancy/breastfeeding (EMA)
• Avoid fennel essential oil during pregnancy
• Fennel tea in moderation may be acceptable but data is limited

Clinical Dosage

Forms and Ranges

• Crushed fennel fruit (tea): 1.5-2.5 g freshly crushed fruit in 150 mL boiling water, steeped 15 minutes, 2-3 times daily
• Fennel honey/syrup (for children): Traditional European preparation; dosage varies by age
• Essential oil (sweet fennel): 0.1-0.6 mL daily (for adults only; bitter fennel oil monograph withdrawn)
• Infants (colic): Fennel seed oil emulsion 0.1% in water, 5-20 mL up to 4 times daily (clinical trial dosage)

Duration Limits (EMA)

• Adults and adolescents: Maximum 2 weeks
• Children 4-12 years: Maximum 1 week
• Children under 4 years: Not recommended as tea without medical supervision

Key Standardized Products

• Fencheltee (fennel tea) — widely available in German pharmacies, including pediatric formulations
• Component of numerous European carminative combination teas (Vier-Winde-Tee, etc.)
• Foeniculi fructus preparations per European Pharmacopoeia (minimum 2% essential oil for bitter fennel fruit)

Sources

• EMA/HMPC Assessment Report on Foeniculum vulgare Miller, fructus (Revision 1)
• EMA/HMPC Herbal Monograph on Foeniculum vulgare, fructus (sweet and bitter varieties)
• HMPC Public Statement on the use of herbal medicinal products containing estragole
• Commission E Monograph: Foeniculi fructus
• ESCOP Monographs: Foeniculi fructus; Foeniculi aetheroleum
• Alexandrovich I, et al. The effect of fennel (Foeniculum vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study. Altern Ther Health Med. 2003;9(4):58-61
• Gori L, et al. Can estragole in fennel seed decoctions really be considered a danger for human health? A fennel safety update. Evid Based Complement Alternat Med. 2012;2012:860542
• Annahazi A, et al. Fennel tea has a region-specific effect on the motility of the stomach. Neurogastroenterol Motil. 2025 (in press)
• Arzneipflanzenlexikon: Fennel (arzneipflanzenlexikon.info)

Connections

• Related to Caraway as fellow Apiaceae family carminative
• Component of STW 5/Iberogast (not directly, but related carminative tradition)
• Compare with German Chamomile for overlapping antispasmodic / pediatric colic use
• The estragole safety debate connects to broader regulatory themes in European phytotherapy